Research Paper Volume 15, Issue 24 pp 15473—15488
Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study
Figure 2. Cancer types of enrolled patients.
Figure 2. Cancer types of enrolled patients.